Logo for GeneDx Holdings Corp

GeneDx Investor Relations Material

Latest events

Logo for GeneDx Holdings Corp

Q4 2023

GeneDx
Logo for GeneDx

Q4 2023

20 Feb, 2024
Logo for GeneDx

Q3 2023

30 Oct, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Segment Data
Access more data
Revenue by
Source
Diagnostic test revenue
Other
Expenses by
Financials
GeneDx Holdings Corp (formerly Sema4) is a patient-centered health intelligence company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease. This data-driven approach to making medicine more precise and personalized starts with patients, clinicians, and health system leaders working together with GeneDx. Founded as Mount Sinai Health System’s predictive health initiative in 2013, GeneDx leverages Mount Sinai’s expertise in genomics, emerging technologies, and population health data to power its proprietary algorithms to drive insights and actions that empower individuals to live longer lives. GeneDx Holdings Corp is headquartered in Stamford, Connecticut.